Transient silencing of synaptic transmitter release from specific neuronal types by recombinant tetanus toxin light chain fused to antibody variable region

J Neurosci Methods. 2008 Oct 30;175(1):125-32. doi: 10.1016/j.jneumeth.2008.08.014. Epub 2008 Aug 19.


We developed a novel strategy for conditional silencing of synaptic transmission in specific neuronal types in transgenic animals. We generated a recombinant protein termed immuno-tetanus toxin (ITet), which contains a monoclonal antibody variable region for human interleukin-2 receptor alpha-subunit (IL-2Ralpha) fused to tetanus toxin light chain. ITet was designed to transiently suppress transmitter release from target neurons genetically engineered to express human IL-2Ralpha via proteolytic cleavage of vesicle-associated membrane protein-2 (VAMP-2). The in vivo actions of ITet were investigated by using mutant mice that express IL-2Ralpha in striatal neurons under the control of the gene encoding dopamine D(2) receptor. Unilateral ITet injection into the striatum induced rotational behavior in the mutant mice and the rotations gradually reversed to the normal level. The behavioral alteration was accompanied by a transient decrease in the striatal VAMP-2 level and depolarization-evoked transmitter release in synaptic target region. However, ITet injection caused no structural change in striatal cells and nerve terminals in the mutants. These data indicate that ITet acts on striatal neurons bearing human IL-2Ralpha and temporally reduces their VAMP-2 content, thereby causing the blockade of transmitter release. Our ITet technology provides a useful approach for inducible and reversible control of synaptic transmission in specific neuronal types in the brain.

Publication types

  • Research Support, N.I.H., Intramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analysis of Variance
  • Animals
  • Antibodies / pharmacology
  • Behavior, Animal / drug effects
  • Chromatography, High Pressure Liquid / methods
  • Corpus Striatum / cytology
  • Functional Laterality
  • Humans
  • Interleukin-2 Receptor alpha Subunit / genetics
  • Interleukin-2 Receptor alpha Subunit / immunology
  • Interleukin-2 Receptor alpha Subunit / metabolism
  • Mice
  • Mice, Transgenic
  • Neurons / drug effects*
  • Neurotransmitter Agents / metabolism*
  • Potassium Chloride / pharmacology
  • Receptors, Dopamine D2 / genetics
  • Recombinant Fusion Proteins / chemistry
  • Recombinant Fusion Proteins / pharmacology
  • Tetanus Toxin / chemistry
  • Tetanus Toxin / pharmacology*
  • Time Factors
  • Vesicle-Associated Membrane Protein 2 / metabolism
  • gamma-Aminobutyric Acid / metabolism


  • Antibodies
  • Interleukin-2 Receptor alpha Subunit
  • Neurotransmitter Agents
  • Receptors, Dopamine D2
  • Recombinant Fusion Proteins
  • Tetanus Toxin
  • Vesicle-Associated Membrane Protein 2
  • gamma-Aminobutyric Acid
  • Potassium Chloride